Roth; Bruce D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roth; Bruce D..The latest application filed is for "functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor".

Company Profile

0.20.2

Roth; Bruce D. - Plymouth MI
Roth; Bruce D. - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor Grant 6,951,848 - Harriman , et al. October 4, 2	2005-10-04
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor App 20050075348 - Harriman, Geraldine C.B. ; et al.	2005-04-07
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor App 20030064991 - Harriman, Geraldine C.B. ; et al.	2003-04-03
Apparatus and method for multiple simultaneous synthesis Grant 5,612,002 - Cody , et al. March 18, 1	1997-03-18
Method for lowering plasma levels of lipoprotein (a) Grant 5,489,611 - Lee , et al. February 6, 1	1996-02-06
[(Hydroxyphenylamino) carbonyl] pyrroles Grant 5,385,929 - Bjorge , et al. January 31, 1	1995-01-31
Apparatus for multiple simultaneous synthesis Grant 5,324,483 - Cody , et al. June 28, 1	1994-06-28
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis Grant 5,280,126 - Butler , et al. January 18, 1	1994-01-18
[R-(RR)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-( 1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof Grant 5,273,995 - Roth December 28, 1	1993-12-28
Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one inhibitors of cholesterol synthesis Grant 5,124,482 - Butler , et al. June 23, 1	1992-06-23
Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis Grant 5,102,893 - Picard , et al. April 7, 1	1992-04-07
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis Grant 5,097,045 - Butler , et al. March 17, 1	1992-03-17
Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis Grant 5,003,080 - Butler , et al. March 26, 1	1991-03-26
Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis Grant 4,957,971 - Picard , et al. September 18, 1	1990-09-18
6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis Grant 4,906,624 - Chucholowski , et al. March 6, 1	1990-03-06
6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis Grant 4,868,185 - Chucholowski , et al. September 19, 1	1989-09-19
6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis Grant 4,761,419 - Picard , et al. August 2, 1	1988-08-02
Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles Grant 4,751,229 - Heifetz , et al. June 14, 1	1988-06-14
Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase Grant 4,743,605 - Hoefle , et al. May 10, 1	1988-05-10
Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase Grant 4,716,175 - Hoefle , et al. December 29, 1	1987-12-29
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis Grant 4,681,893 - Roth July 21, 1	1987-07-21
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis Grant 4,647,576 - Hoefle , et al. March 3, 1	1987-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.